Patient Safety

Personalized Anesthesia Through Pharmacogenomics (1 Class A CE with 1 Pharm)

Saturday, September 22
11:45 AM - 12:45 PM
Location: Ballroom A, Hynes

This presentation will address the pharmacogenomic-driven implication of pharmacodynamic and pharmacokinetic drug responses. The use of pharmacogenomic testing in anesthesia practice is novel and studies show that pharmacogenomic testing can decrease adverse drug reactions while increasing drug efficacy. A real world example of interpretation and application of pharmacogenomic testing will be discussed. The use of pharmacogenomic testing as a way to inform clinical decision-making in the context of opioid reduction/sparing analgesia will be the focus of this talk.

Learning Objectives:

Dru Riddle, PhD, DNP, CRNA

Associate Professor
Texas Christian University
Fort Worth, Texas

Dru is an Associate Professor of Professional Practice at Texas Christian University School of Nurse Anesthesia, Fort Worth, Texas. He also serves as the Director of the Center for Translational Research: A JBI Center of Excellence. Dru is a Certified Registered Nurse Anesthetist and maintains an active clinical anesthesia practice. He completed his nursing and nurse anesthesia training in Virginia, his DNP at Texas Christian University, and his PhD in pharmacogenomics at the Medical University of South Carolina. He will be inducted as a Fellow in the American Academy of Nursing in November, 2018.

Dru’s research interest included evidence based healthcare, pharmacogenomics, and genetic implications for anesthesia care. Additionally, he has spoken nationally and internationally on evidence based healthcare, systematic review strategies, and various clinical anesthesia topics.

Presentation(s):

Send Email for Dru Riddle


Assets

Personalized Anesthesia Through Pharmacogenomics (1 Class A CE with 1 Pharm)

Slides

Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Personalized Anesthesia Through Pharmacogenomics (1 Class A CE with 1 Pharm)